Given the clinical significance of these toxicities, our analysis of stomatitis signals in FAERS provides important insight into how oral adverse events are reported with PI3K, AKT, mTOR, and CDK4/6 inhibitors, and highlights the need for systematic monitoring of oral health in patients treated with targeted therapies. This evidence concerns the gene CDK4 and stomatitis.